論文使用權限 Thesis access permission:校內立即公開,校外一年後公開 off campus withheld
開放時間 Available:
校內 Campus: 已公開 available
校外 Off-campus: 已公開 available
論文名稱 Title |
鯽魚膽水萃物對硫代乙醯胺誘發小鼠肝纖維化的
保護作用 Hepatoprotective Effects of Pluchea indica (L.) Less. Aqueous Extract against Thioacetamide-induced Liver Fibrosis in Mice |
||
系所名稱 Department |
|||
畢業學年期 Year, semester |
語文別 Language |
||
學位類別 Degree |
頁數 Number of pages |
70 |
|
研究生 Author |
|||
指導教授 Advisor |
|||
召集委員 Convenor |
|||
口試委員 Advisory Committee |
|||
口試日期 Date of Exam |
2009-06-29 |
繳交日期 Date of Submission |
2009-09-08 |
關鍵字 Keywords |
Hydroxyproline、Sirius red染色、硫代乙醯胺、肝纖維化、鯽魚膽 Hydroxyproline, Sirius red staining, Thioacetamide, Liver fibrosis, Pluchea indica |
||
統計 Statistics |
本論文已被瀏覽 5727 次,被下載 2166 次 The thesis/dissertation has been browsed 5727 times, has been downloaded 2166 times. |
中文摘要 |
肝纖維化是諸多病因導致慢性肝病的共同病理過程,目前尚未有很好的 抗肝纖維化藥物,草藥在抗肝纖維化應用深具潛力。本研究探討草藥鯽魚 膽(Pluchea indica)的根水萃物能否降低硫代乙醯胺(thioacetamide; TAA)所 誘發小鼠(BALB/c)肝纖維化。實驗組小鼠每週腹腔注射三次TAA(200 mg/Kg);治療組則除TAA注射外,每週腹腔注射一次鯽魚膽的根水萃物 (PIAE),水萃物濃度分成低中高三種不同劑量(0.5, 1.0, 和1.5mg/ml);控制 組每週腹腔注射三次磷酸鹽緩衝液(PBS, 2 ml/Kg)。小鼠連續處理四週或八 週後,檢測血清glutamyl pyruvic transaminase (GPT)活性,結果發現注射TAA 四週及八週的GPT活性都高於控制組,中劑量及高劑量治療組GPT活性明 顯降低。肝組織切片以Hematoxylin & Eosin、Reticular fiber和Sirius red染色 結果發現TAA誘發纖維化,而治療組纖維化程度減輕。Hydroxyproline分析 指出TAA會使肝臟collagen含量增加,治療組在四週與八週collagen含量會 降低。膠原蛋白α1型和α-肌動蛋白基因表現量則在PIAE治療四週與八週顯 著降低。CD163(ED2)、α-肌動蛋白、p53、和磷酸化p53之蛋白質表現量, PIAE治療明顯低於TAA處理。本研究結果證實鯽魚膽的根水萃物可抑制肝 臟膠原蛋白的合成,降低肝纖維化形成。 |
Abstract |
Typically chronic injury leads to hepatic fibrosis. No effective antifibrotic drugs have been approved, but herbal drugs have potential on the therapy of hepatic fibrosis. The objective of this study used TAA-induced liver fibrosis mouse as a model to elucidate whether aqueous extract of the root of Pluchea indica (PIAE) can reduce liver fibrosis triggered by TAA. Mice were intraperitoneally injected with TAA (200 mg/Kg) three times per week as the TAA group, and those of injected with PIAE once per week as the treatment group. Three PIAE dosages of low- (0.5 mg/ml), medium- (1.0 mg/ml), and high- (1.5 mg/ml) doses were applied. Control mice were intraperitoneally injected with phosphate-buffered saline (2 ml/Kg) three times per week. Mice were sacrificed after 4 or 8 week treatment. Mice serum glutamyl pyruvic transaminases (GPT) were increased in the TAA group while the treatment group effects were declined after 4 or 8 weeks. H&E, Reticular fiber, and Sirius red staining revealed that TAA induced liver fibrosis and fibrotic lesions were reduced by PIAE treatment. Hydroxyproline assay showed that TAA increased collagen contents and PIAE significantly decreased collagen contents after 4 or 8 weeks. Collagen α1 and α-SMA mRNA levels were decreased after 4- or 8- week PIAE treatments. The protein levels of ED2, α-SMA, p53, and phospho-p53 were all significantly declined on 4 or 8 weeks after PIAE treatment. In conclusion, these results demonstrated that the aqueous extract of P. indica shows anti-fibrotic effects on fibrogenesis of mouse liver. |
目次 Table of Contents |
Contents Abstract in Chinese ---------------------------------------------------------------------I Abstract in English ---------------------------------------------------------------------II Acknowledgements --------------------------------------------------------------------III Abbreviation ----------------------------------------------------------------------------V Introduction ------------------------------------------------------------------------------1 Mechanism of liver fibrosis --------------------------------------------------------1 Treatment of liver fibrosis ----------------------------------------------------------2 Pluchea indica (L.) Less. -----------------------------------------------------------3 Apply of Pluchea indica (L.) Less. ------------------------------------------------5 Research of Pluchea indica (L.) Less. --------------------------------------------6 Materials and Methods ----------------------------------------------------------------8 Plant material -------------------------------------------------------------------------8 Animal grouping and treatment ----------------------------------------------------8 Specimen collection and Biochemistry assay ------------------------------------9 Histological examination -----------------------------------------------------------9 Hydroxyproline assay --------------------------------------------------------------13 Quantitative real-time PCR analysis ---------------------------------------------13 Western blot analysis --------------------------------------------------------------15 VII Statistical analysis ------------------------------------------------------------------18 Results -----------------------------------------------------------------------------------19 Serum GPT activity ----------------------------------------------------------------19 Histological changes of the liver -------------------------------------------------19 Liver hydroxyproline contents ----------------------------------------------------20 mRNA expression of collagen α1 and α-SMA ---------------------------------20 Protein expression of ED2, α-SMA, p53, and Phospho-p53 -----------------21 Discussion -------------------------------------------------------------------------------23 References -------------------------------------------------------------------------------26 Table -------------------------------------------------------------------------------------36 Figure ------------------------------------------------------------------------------------44 Appendix --------------------------------------------------------------------------------58 |
參考文獻 References |
References Alam MI, Auddy B, Gomes A. Viper venom neutralization by Indian medicinal plant (Hemidesmus indicus and Pluchea indica) root extracts. Phytother Res 1996; 10:58-61. Arthur MJ. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 2002; 122:1525-1528. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001; 21:437-451. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115:209-218. Bergheim I, Guo L, Davis MA, Duveau I, Arteel GE. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 2006; 316:592-600. Biswas R, Dasgupta A, Mitra A, Roy SK, Dutta PK, Achari B, Dastidar SG, Chatterjee TK. Isolation, purification and characterization of four pure compounds from the root extract of Pluchea indica (L.) Less. and the potentiality of the root extract and the pure compounds for antimicrobial activity. European Bulletin Drug Res 2005; 13:63-70. Biswas R, Dutta PK, Achari B, Bandyopadhyay D, Mishra M, Pramanik KC, Chatterjee TK. Isolation of pure compound R/J/3 from Pluchea indica (L.) Less. and its anti-amoebic activities against Entamoeba histolytica. Phytomedicine 2007; 14:534-537. Burkitt H, Young B, Heath J. Wheater's functional histology. In: Wheater's functional histology. 3rd ed. Churchill Livingstone 1993; 62. Cater CM, Rhee KC, Hagenmaier RD, Mattil KF. Aqueous extraction-an alternative oilseed milling. J Am Oil Chem Soc 1973; 51:137-141 Cawston TE. Proteinases and inhibitor. Br Med Bull 1995; 51:385-401. Chakravarty AK, Mukhopadhyay S. New thiophene derivatives from Pluchea indica. Indian J Chem 1994; 33:978-980. Chatterjee S, Vrolix G, Depoortere I, Peeters T, Van Marck E. The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis. BMC Infect Dis 2005; 5:45. Chatterjee TK. Herbal Options, M/s Eastern Traders, Calcutta, India 1996; 183-215. Darby I, Skalli O, Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990; 63:21-29. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003; 9:331-338. Flora of Taiwan. 1998; 4:1034-1036. Friedman SL. Liver fibrosis -- from bench to bedside. J Hepatol 2003; 38 (Suppl):S38-S53. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A 1985; 82:8681-8685. Gabele E, Brenner DA, Rippe RA. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 2003; 8:69-77. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 2001; 21:311-335. Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med 2004; 350:1646-1654. Gomes A, Saha A, Chatterjee I, Chakravarty AK. Viper and cobra venom neutralization by beta-sitosterol and stigmasterol isolated from the root extract of Pluchea indica Less. (Asteraceae). Phytomedicine 2007; 14:637-643. Hart DN, Fabre JW. Passive enhancement of rat renal allografts using mouse monoclonal xenoantibodies. Transplantation 1981; 32:431-435. Hong SH, Seo SH, Lee JH, Choi BT. The aqueous extract from Artemisia capillaris Thunb. inhibits lipopolysaccharide-induced inflammatory response through preventing NF-kappaB activation in human hepatoma cell line and rat liver. Int J Mol Med 2004; 13:717-720. Hsieh CL, Cheng CY, Tsai TH, Lin IH, Liu CH, Chiang SY, Lin JG, Lao CJ, Tang NY. Paeonol reduced cerebral infarction involving the superoxide anion and microglia activation in ischemia-reperfusion injured rats. J Ethnopharmacol 2006; 106:208-215. Huang HL, Chen CC, Yeh CY, Huang RL. Reactive oxygen species mediation of baizhu-induced apoptosis in human leukemia cells. J Ethnopharmacol 2005; 97:21-29. IARC. Chemicals, Industrial Processes and Industries Associated with Cancer in Humans. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Supplement 4. Lyon, France: International Agency for Research on Cancer, WHO, 1982; 292 pp. IARC. Some Anti-thyroid and Related Substances, Nitrofurans and Industrial Chemicals. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, vol. 7. Lyon, France: International Agency for Research on Cancer, WHO, 1974; 326 pp. Junqueira LCU, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979; 11:447-455 Kamboj VP. Herbal medicine. Curr Sci 2000; 78:35-39. Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol 2001; 161: III-XIII, 1-151. Li XK, Motwani M, Tong W, Bornmann W, Schwartz GK. Huanglian, A chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol Pharmacol 2000; 58:1287-1293. Mahapatra PK, Chaudhuri AK. Neuropharmacological Studies on Pluchea indica. Planta Med 1986; 52:546-547. Mangipudy RS, Rao PS, Andrews A, Bucci TJ, Witzmann FA, Mehendale HM. Dose dependent modulation of cell death: apoptosis versus necrosis in thioacetamide hepatotoxicity. Int J Toxicol 1998; 17:193-211. Mukhopadhyay S, Cordell GA, Ruangrungsi N, Rodkird S, Tantivatana P, Hylands PJ. Traditional medicinal plants of Thailand. IV. 3-(2’, 3’-Diacetoxy-2’-methyl butyryl)- cuauhtemone from Pluchea indica. J Nat Prod 1983; 46:671-674. Nan JX, Park EJ, Kim YC, Ko G, Sohn DH. Scutellaria baicalensis inhibits liver fibrosis induced by bile duct ligation or carbon tetrachloride in rats. J Pharm Pharmacol 2002; 54:555-563. Ohtsuki T, Yokosawa E, Koyano T, Preeprame S, Kowithayakorn T, Sakai S, Toida T, Ishibashi M. Quinic acid esters from Pluchea indica with collagenase, MMP-2 and MMP-9 inhibitory activities. Phytother Res 2008; 22:264-266. Pal S, Nag Chaudhuri AK. Studies on the effect of Pluchea indica Less. root extract on gastroduodenal ulcer models in rats and guinea pig. Phytother Res. 1989; 3:156-158. Park EJ, Zhao YZ, Lian L, Kim YC, Sohn DH. Skullcapflavone I from Scutellaria baicalensis induces apoptosis in activated rat hepatic stellate cells. Planta Med 2005; 71:885-887. Park WH, Lee SK, Kim CH. A Korean herbal medicine, Panax notoginseng, prevents liver fibrosis and hepatic microvascular dysfunction in rats. Life Sci 2005; 76:1675-1690. Peng CI, Chen CH, Leu WP, Yen HF. Pluchea Cass. (Asteraceae: Inuleae) in Taiwan. Bot Bull Acad Sin 1998; 39:287-297. Pinzani M. Liver fibrosis. Springer Semin Immunopathol 1999; 21:475-490. Popper H, Uenfriend S. Hepatic fibrosis. Correlation of biochemical and morphologic investigations. Am J Med 1970; 49:707-721. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349:825-832. Poynard T, Ratziu V, Benhamou Y, Opolon P, Cacoub P, Bedossa P. Natural history of HCV infection. Baillieres Best Pract Res Clin Gastroenterol 2000; 14:211-228. Pramanik KC, Bhattacharya P, Biswas R, Bandyopadhyay D, Mishra M, Chatterjee TK. Hypoglycemic and antihyperglycemic activity of leaf extract of Pluchea indica Less. Orient Pharm Exp Med 2006; 6:232-236. Pramanik KC, Biswas R, Mitra A, Bandyopadhyay D, Mishra M, Chatterjee TK. Tissue Culture of the plant Pluchea indica (L.) Less. and Evaluation of Diuretic Potential of its Leaves. Orient Pharm Exp Med 2007; 7:197-204. Pramanik KC, Chatterjee TK. In vitro and In vivo Antibacterial Activities of root extract of tissue cultured Pluchea indica (L.) Less. against bacillary dysentery. Phcog Mag 2008; 4:78-84 Puchtler H, Waldrop FS, Valentine LS. Polarization microscopic studies of connective tissue stained with picro-sirius red FBA. Beitr Path 1973; 150: 174-187 Ramaiah SK, Apte UM, Mehendale HM. Diet restriction as a protective mechanism in noncancer toxicity outcomes. A review. Int J Toxicol 2000; 19:413-429. Ryu G, Park EK, Joo JH, Lee BH, Choi BW, Jung DS, Lee NH. A new antioxidant monoterpene glycoside, alpha-benzoyloxypaeoniflorin from Paeonia suffruticosa. Arch Pharm Res 2001; 24:105-108. Scheig R. Evaluation of tests used to screen patients with liver disorders. Prim Care 1996; 23:551-560. Sen T, Basu A, Ray RN, Nag Chaudhuri AK. Hepatoprotective effect of Pluchea indica (Less.) extract in experimental acute liver damage in rodents. Phytother Res. 1993; 7:352-355. Sen T, Dhara AK, Bhattacharjee S, Pal S, Nag Chaudhuri AK. Antioxidant activity of the methanol fraction of Pluchea indica root extract. Phytother Res 2002; 16:331-335. Sen T, Ghosh TK, Chaudhuri AK. Studies on the mechanism of anti-inflammatory and anti-ulcer activity of Pluchea indica--probable involvement of 5-lipooxygenase pathway. Life Sci 1993; 52:737-743. Sen T, Ghosh TK, Chaudhuri AK. Glucose oxidase-induced lysis of erythrocytes. Indian J Exp Biol 1995; 33:75-76. Sen T, Nag Chaudhuri AK. Antiinflammatory evaluation of a Pluchea indica root extract. J Ethnopharmacol 1991; 33:135-141. Soyer MT, Ceballos R, Aldrete JS. Reversibility of severe hepatic damage caused by jejunoileal bypass after re-establishment of normal intestinal continuity. Surgery 1976; 79:601-604. Stone BC. The flora of Guam. Micronesica 1970; 6:589. Thongpraditchote S, Matsumoto K, Temsiririrkkul R, Tohda M, Murakami Y, Watanabe H. Neuropharmacological actions of Pluchea indica Less root extract in socially isolated mice. Biol Pharm Bull 1996; 19:379-383. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3:349-363. Uchiyama T, Miyase T, Ueno A, Usmanghani K. Terpenic glycosides from Pluchea indica. Phytochem 1989; 28:3369-3372. Uchiyama T, Miyase T, Ueno A, Usmanghani K. Terpene and lignan glycosides from Pluchea indica. Phytochem 1991; 30:655-657. Van der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991; 5: 2814-2823. Wagner WL, Herbst DR, Sohmer SH. Manual of the flowering plants of Hawai'i. Honolulu, HI: University of Hawaii Press: Bishop Museum Press 1999; 2:351. Wasser S, Ho JM, Ang HK, Tan CE. Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats. J Hepatol 1998; 29:760-771. Wasser S, Tan CE. Experimental models of hepatic fibrosis in the rat. Ann Acad Med Singapore 1999; 28:109-111. Woessner JF, Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961; 93:440-447. Zhang BZ, Ding F, Tan LW. [Clinical and experimental study on yi-gan-ning granule in treating chronic hepatitis B]. Zhongguo Zhong Xi Yi Jie He Za Zhi 1993; 13:597-599. Zhang XL, Liu L, Jiang HQ. Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis via caspase-3 activation. World J Gastroenterol 2002; 8:515-519. Zhang Y, Ye QF, Lu L, Xu XL, Ming YZ, Xiao JS. Panax notoginseng saponins preconditioning protects rat liver grafts from ischemia/reperfusion injury via an antiapoptotic pathway. Hepatobiliary Pancreat Dis Int 2005; 4:207-212. Zhan Y, Li D, Wei H. [Effect of emodin on development of hepatic fibrosis in rats]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000; 20:276-278. http://www.cych.org.tw/cych/medknow/100/02.htm http://www.doh.gov.tw/EN2006/index_EN.aspx 陳玉樹,2002。鹽與乾旱逆境對屋山頂火山地區植物分佈之影響,碩士論 文,國立高雄師範大學生物科學研究所。 陳虹妃,2003。氯化鈉對鯽魚膽切離葉片之影響,碩士論文,國立高雄師 範大學生物科學研究所。 曹淑娟,2007。探討鯽魚膽根與葉之水萃物對癌細胞的影響,碩士論文, 國立中山大學生物科學系研究所。 |
電子全文 Fulltext |
本電子全文僅授權使用者為學術研究之目的,進行個人非營利性質之檢索、閱讀、列印。請遵守中華民國著作權法之相關規定,切勿任意重製、散佈、改作、轉貼、播送,以免觸法。 論文使用權限 Thesis access permission:校內立即公開,校外一年後公開 off campus withheld 開放時間 Available: 校內 Campus: 已公開 available 校外 Off-campus: 已公開 available |
紙本論文 Printed copies |
紙本論文的公開資訊在102學年度以後相對較為完整。如果需要查詢101學年度以前的紙本論文公開資訊,請聯繫圖資處紙本論文服務櫃台。如有不便之處敬請見諒。 開放時間 available 已公開 available |
QR Code |